Hoge Stephen's Form 4 filing
Moderna, Inc. (MRNA) · filed Jan 14, 2022
- Accession no.
- 0001127602-22-001516
- Filed
- Jan 14, 2022
- Trade date
- Jan 12-13, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $4.39M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoge StephenCIK 0001760669 | Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2022 | Common Stock | MOption exerciseAcquired | +5,000 | $10.90 | +$54,500 | 1,614,597 | Direct | |
| Jan 12, 2022 | Common Stock | SSaleDisposed | −5,000 | $220.01 | −$1,100,050 | 1,609,597 | Direct | |
| Jan 13, 2022 | Common Stock | MOption exerciseAcquired | +5,000 | $10.90 | +$54,500 | 1,614,597 | Direct | |
| Jan 13, 2022 | Common Stock | MOption exerciseAcquired | +10,000 | $0.99 | +$9,900 | 1,624,597 | Direct | |
| Jan 13, 2022 | Common Stock | SSaleDisposed | −15,000 | $219.56 | −$3,293,400 | 1,609,597 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2022 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 161,972 | Direct | |
| Jan 13, 2022 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 156,972 | Direct | |
| Jan 13, 2022 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 167,431 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.